Pfizer Ventures
Overview
Backs therapeutics, platform technologies, diagnostics, drug delivery, pharma services, healthcare IT + technologies impacting drug discovery and development.
Investment Focus
- Innovative healthcare solutions
- Alignment with Pfizer's therapeutic areas
- Potential for strategic partnership with Pfizer
- Strong management team
- Scalable business model
- Clear regulatory pathway
- Competitive market positioning
- Demonstrated clinical or preclinical efficacy
- Potential for significant patient impact
- Ability to leverage Pfizer's global reach
Portfolio Companies
Reach Pfizer Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Pfizer Ventures
What sectors does Pfizer Ventures invest in?
Pfizer Ventures invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in New York, New York, United States. Pfizer Ventures is listed as a corporate vc in the ConnectSafely investor database.
What stage does Pfizer Ventures invest at?
Pfizer Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Pfizer Ventures invest in?
Pfizer Ventures invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Pfizer Ventures invested in?
Pfizer Ventures's portfolio includes CureVac, Medivation, Arena Pharmaceuticals, Array BioPharma, Trillium Therapeutics, Therachon, Anacor Pharmaceuticals and BIND Therapeutics.
How do I contact Pfizer Ventures?
Pfizer Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
